Researchers have known for nearly 40 years that HDL occurs naturally in some people, including the inhabitants of a small northern Italian village who have a much lower rate of heart disease. A genetically engineered form, ApoA-1 Milano, has now been created by Michigan research company Esperion Therapeutics.